Moreover, the preferential expression of the hypoxic and castration resistance gene set within the Cases group of the Porto cohort and the identification of ZNF560 in the CPC-Gene cohort demonstrate there is a chronic hypoxia mechanism involved in prostate cancer progression. This evidence concerns the gene ZNF560 and prostate carcinoma.